Glivec (imatinib) CML and GIST Treatment Glivec, CML, and GIST Treatment Information for International Healthcare Professionals Glivec, CML and GIST Treatment Information for US Residents International Glivec Information from Novartis Oncology Click here to go to Novartis.com Novartis Oncology International Site
International Glivec Information from Novartis Oncology
Ask a question

Help us improve Glivec.com.
Please take our short survey.



SIGN UP TO RECEIVE ONCOLOGY AND HAEMATOLOGY NEWS

Haematology News is a current news service provided by Doctor's Guide®. Novartis accepts no responsibility for and makes no representations or warranties regarding the content of the information presented.

In each weekly edition, you'll receive general news in the fields of haematology and oncology, as well as up-to-date information on chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs). Specifically, newsletters will include:

  • Top peer-reviewed news and abstracts from over 2,200 medical journals
  • Written reviews from major medical congresses
  • Haematology and oncology news
  • Links to imatinib resources
  • Links to CME and Webcasting
All fields are required.
     
First Name:
Last Name:
Email Address:
Medical Specialty:
City:
Country:
 

Unsubscribe | Privacy Policy

 

Disclaimer: This is an international website for Glivec (imatinib) and is intended for healthcare professionals outside the US. If you are a US resident, please click on the For US Residents link at the top of this page. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.



Use of this website is subject to our Terms of Use.
© 2008 Novartis Pharma AG